Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02227914 |
| Title | Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Onyx Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Lahey Hospital & Medical Center | Burlington | California | United States | Details | ||
| Rocky Mountain Cancer Centers | Denver | Colorado | United States | Details | ||
| University of Miami Hospital & Clinics | Miami | Florida | United States | Details | ||
| The University of Chicago Medical Center | Chicago | Illinois | United States | Details | ||
| The Ohio State University, Martha Morehouse Medical Plaza | Columbus | Ohio | United States | Details | ||
| University of Wisconsin Comprehensive Cancer Center | Madison | Wisconsin | United States | Details |